[1] Scott JK, Smith GP. Searching for peptide ligands with an epitope library. Science, 1990, 249(4967): 386-390.  doi: 10.1126/science.1696028
[2] Pasqualini R, Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature, 1996, 380(6572): 364-366.  doi: 10.1038/380364a0
[3] Pasqualini R, Koivunen E, Ruoslahti E. Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol, 1997, 15(6): 542-546.  doi: 10.1038/nbt0697-542
[4] Lee TY, Lin CT, Kuo SY, et al. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery. Cancer Res, 2007, 67(22): 10958-10965.  doi: 10.1158/0008-5472.CAN-07-2233
[5] Yang W, Luo D, Wang S, et al. TMTP1, a novel tumor-homing peptide specifically targeting metastasis. Clin Cancer Res, 2008, 14(17): 5494-5502.  doi: 10.1158/1078-0432.CCR-08-0233
[6] Hui X, Han Y, Liang S, et al. Specific targeting of the vascul-ature of gastric cancer by a new tumor-homing peptide CGNSNPKSC. J Control Release, 2008, 131(2): 86-93.  doi: 10.1016/j.jconrel.2008.07.024
[7] Du B, Han H, Wang Z, et al. Targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding Peptide. Mol Cancer Res, 2010, 8(2): 135-144.  doi: 10.1158/1541-7786.MCR-09-0339
[8] Chen B, Cao S, Zhang Y, et al. A novel peptide (GX1) homing to gastric cancer vasculature inhibits angiogenesis and cooperates with TNF alpha in anti-tumor therapy. BMC Cell Biol, 2009, 10: 63.  doi: 10.1186/1471-2121-10-63
[9] Zhang L, Hoffman JA, Ruoslahti E, et al. Molecular profiling of heart endothelial cells. Circulation, 2005, 112(11): 1601-1611.  doi: 10.1161/CIRCULATIONAHA.104.529537
[10] Garces CA, Kurenova EV, Golubovskaya VM, et al. Vascular endothelial growth factor receptor-3 and focal adhesion kinase bind and suppress apoptosis in breast cancer cells. Cancer Res, 2006, 66(3): 1446-1454.  doi: 10.1158/0008-5472.CAN-05-1661
[11] Howell RC, Revskaya E, Pazo V, et al. Phage display library derived peptides that bind to human tumor melanin as potential vehicles for targeted radionuclide therapy of metastatic melanoma. Bioconjug Chem, 2007, 18(6): 1739-1748.  doi: 10.1021/bc060330u
[12] Zitzmann S, Krämer S, Mier W, et al. Identification and evaluation of a new tumor cell-binding peptide, FROP-1. J Nucl Med, 2007, 48(6): 965-972.  doi: 10.2967/jnumed.106.036699
[13] Zitzmann S, Mier W, Schad A, et al. A new prostate carcinoma binding peptide (DUP-1)for tumor imaging and therapy. Clin Cancer Res, 2005, 11(1): 139-146.
[14] 王月英, 周继文, 穆传杰, 等. IRM-2近交系小鼠肿瘤模型的建立. 中国比较医学杂志, 2003, 13(4): 246-248.  doi: 10.3969/j.issn.1671-7856.2003.04.016
[15]

Ries L, Eisner MP, Kosary CL, et al. SEER cancer statistics review, 1973-1997. USA: National Cancer Institute, 2000: 1-7.
[16] Strauss GM. Randomized population trials and screening for lung cancer: breaking the cure barrier. Cancer, 2000, 89(11 Suppl): 2399-2421.